Meta (META) CPO granted new RSUs and price-based stock options

Rhea-AI Filing Summary

Meta Platforms’ Chief Product Officer Christopher K. Cox received new equity awards as compensation. On March 20, 2026, he was granted 79,324 Restricted Stock Units, each convertible into one share of Class A common stock. These RSUs vest in 16 quarterly installments starting on May 15, 2026, contingent on continued service.

On the same date he was also granted several stock option tranches to buy Class A shares, including 12,806 options at an exercise price of $1,116.08 per share and additional tranches at exercise prices up to $3,727.12 per share, all expiring on March 19, 2031. The options vest based on Meta’s share price meeting or exceeding each tranche’s exercise price during a “Price Vesting Period” through February 14, 2028, with remaining unvested options then vesting on a set schedule through August 15, 2030, subject to Cox’s continued service. These are awards, not open‑market purchases or sales.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cox Christopher K

(Last) (First) (Middle)

C/O META PLATFORMS, INC.

1 META WAY

(Street)

MENLO PARK CALIFORNIA 94025

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Meta Platforms, Inc. [ META ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Product Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (RSU) (Class A)	(1)	03/20/2026		A		79,324		(2)	(2)	Class A Common Stock	79,324	$0	79,324	D
Stock Options (right to buy)	$1,116.08	03/20/2026		A		12,806		(3)(4)	03/19/2031	Class A Common Stock	12,806	$0	12,806	D
Stock Options (right to buy)	$1,393.87	03/20/2026		A		18,066		(3)(4)	03/19/2031	Class A Common Stock	18,066	$0	18,066	D
Stock Options (right to buy)	$1,724.41	03/20/2026		A		29,340		(3)(4)	03/19/2031	Class A Common Stock	29,340	$0	29,340	D
Stock Options (right to buy)	$2,114.87	03/20/2026		A		97,541		(3)(4)	03/19/2031	Class A Common Stock	97,541	$0	97,541	D
Stock Options (right to buy)	$2,573.06	03/20/2026		A		155,491		(3)(4)	03/19/2031	Class A Common Stock	155,491	$0	155,491	D
Stock Options (right to buy)	$3,107.44	03/20/2026		A		249,382		(3)(4)	03/19/2031	Class A Common Stock	249,382	$0	249,382	D
Stock Options (right to buy)	$3,727.12	03/20/2026		A		91,239		(3)(4)	03/19/2031	Class A Common Stock	91,239	$0	91,239	D

Explanation of Responses:

1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement.

2. The RSUs vest quarterly as to 1/16th of the total RSUs, beginning on May 15, 2026, subject to continued service through each vesting date.

3. The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date.

4. Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date.

	/s/ Erin Guldiken, attorney-in-fact for Christopher K. Cox	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did Meta (META) Chief Product Officer Christopher Cox receive?

Christopher Cox received new RSU and stock option awards as compensation. He was granted 79,324 Restricted Stock Units and several tranches of stock options with exercise prices ranging from $1,116.08 to $3,727.12 per share, all tied to continued service and vesting conditions.

How do Christopher Cox’s new RSUs at Meta (META) vest?

The 79,324 RSUs granted to Christopher Cox vest quarterly over 16 installments. Vesting begins on May 15, 2026, with 1/16 of the total vesting each quarter, and each installment requires that he remain in service through the applicable vesting date.

What are the key terms of Christopher Cox’s new Meta (META) stock options?

Cox received multiple stock option tranches to buy Class A shares at exercise prices between $1,116.08 and $3,727.12 per share. All these options expire on March 19, 2031, and vest only if specific price and service-based conditions are met.

How does the price-based vesting period work for Meta (META) options granted to Christopher Cox?

From grant through February 14, 2028, each option tranche fully vests once Meta’s Class A share price on NASDAQ meets or exceeds that tranche’s exercise price. Vesting also requires Cox’s continued service on the date the price condition is satisfied.

What happens to Christopher Cox’s Meta (META) options if they do not vest during the price vesting period?

Any option tranches not vested by February 14, 2028 shift to a time-based schedule. Those options then vest 6/16 on February 15, 2028, and 1/16 quarterly thereafter, with the final 1/16 vesting on August 15, 2030, subject to continued service.

Do Christopher Cox’s Meta (META) Form 4 transactions involve open-market buying or selling?

The transactions reflect compensation-related grants, not market trades. All entries are coded as “A” for awards, covering RSUs and stock options granted at a per-share transaction price of $0.00, rather than open-market purchases or sales of existing Meta shares.